Nicolas Skuli

Molecular Biology · 2011

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Nicolas Skuli trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Semenza

Papers from Nicolas Skuli's perspective

Ordered by how strongly the researchers Nicolas Skuli trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
  2. Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (Cancer Cell)
  3. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 (Nature Medicine)
  4. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. (Cancer Cell)
  5. Hypoxia requires notch signaling to maintain the undifferentiated cell state. (Developmental Cell)
  6. Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization (Cell)
  7. Angiogenesis in life, disease and medicine (Nature)
  8. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. (Cancer Cell)
  9. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. (Journal of Clinical Investigation)
  10. MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3* (Journal of Biological Chemistry)

Their papers